About the Journal

Translational Andrology and Urology

Translational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, bi-monthly journal (quarterly published from Mar. 2012 - Dec. 2014). TAU delivers up-to-date findings and provides current and practical information on basic and clinical research of andrology and urology. It publishes articles that cover various aspects in diseases of male and female urinary tract including kidneys, ureters, bladder and urethra and the male reproductive organs like penis, testes, scrotum, prostate etc. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.

TAU is indexed in PubMed/PubMed Central, Scopus and Science Citation Index Expanded (SCIE) and the SCIE impact factor 2018 for TAU is 2.113. TAU is endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).

The entire submission and review process are managed through OJS system, an electronic system, which provides an efficient way and ensures a rapid turnaround of papers submitted for publication. Articles will be published both in print and online. See more at Information for Authors.

Manuscripts Turnaround Time:

  • First Editorial Decision: 3-5 days
  • Peer review: 1-2 months
  • Revision time: 2-4 weeks
  • Publication Ahead of Print: within 1 month after being accepted
  • Formal publication: within 1-3 months after being accepted.


The Official Publication of:


AME Publishing Company.

  • Address: Rm C, 16/F, Kings Wing Plaza 1, No. 3 On Kwan Street, Shatin, NT, Hong Kong
  • Phone: +86 20 66355775
  • Email: tau@amepc.org


Updated on March 13, 2019